Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
30m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
58m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Envoy Medical Inc. logo

Envoy Medical Inc.

About

Envoy Medical Inc. (NASDAQ:COCH) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Apr 16 2026
Envoy Medical Appoints Chas McKhann to Board of Directors
Apr 1 2026
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
Mar 23 2026
Envoy Medical Reports Full Year 2025 Financial Results
Mar 11 2026
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

Financials

Revenue
$241 K
Market Cap
$54.2 M
EPS
-1.23

Community Chat

Ask AI

6ix6ixAIEvents